CTC phenotype classifier to identify mCRPC patients (pts) with high genomic instability CTCs and to predict failure of androgen ecreptor signaling (AR Tx) and taxane (T) systemic therapies.

被引:4
|
作者
Scher, Howard I.
Jendrisak, Adam
Graf, Ryon
Schreiber, Nicole A.
McLaughlin, Brigit
Greene, Stephanie
Rodriguez, Angel
Louw, Jessica
Dugan, Lyndsey
Leitz, Laura
Fleisher, Martin
Lee, Jerry
Wang, Yipeng
Landers, Mark Andrew
Dittamore, Ryan Vance
机构
关键词
D O I
10.1200/JCO.2016.34.15_suppl.5044
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5044
引用
收藏
页数:3
相关论文
共 1 条
  • [1] Single CTC characterization to identify phenotypic and genomic heterogeneity as a mechanism of resistance to AR signaling directed therapies (AR Tx) in mCRPC patients.
    Scher, Howard I.
    Graf, Ryon
    Louw, Jessica
    Jendrisak, Adam
    Johnson, Ann
    Greene, Stephanie
    Rodriguez, Angel
    Schreiber, Nicole A.
    McLaughlin, Brigit
    Dugan, Lyndsey
    Fleisher, Martin
    Lee, Jerry
    Wang, Yipeng
    Marrinucci, Dena C.
    Landers, Mark
    Dittamore, Ryan Vance
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)